Medidata announced that Caidya has invested in additional solutions within the Medidata Experiences, including Clinical Trial Management System and Clinical Data Studio. With Medidata already supporting over 80% of its trials, this growing partnership positions Caidya to connect workflows, data, and teams across the trial lifecycle that enables more data-driven decision-making for a variety of therapeutic areas.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DASTY:
- Medidata expands collaboration with National Cancer Institute
- Medidata expands collaboration with CTI Clinical Trial and Consulting
- Dassault Systemes price target lowered to EUR 30.30 from EUR 34 at Berenberg
- Dassault Systemes price target lowered to EUR 23 from EUR 24 at Jefferies
- Dassault Systemes price target lowered to EUR 30 from EUR 33 at JPMorgan